Corpus ID: 30849081

Vincristine-induced peripheral neuropathy in pediatric cancer patients.

@article{Mora2016VincristineinducedPN,
  title={Vincristine-induced peripheral neuropathy in pediatric cancer patients.},
  author={Erika Mora and E. Smith and C. Donohoe and D. Hertz},
  journal={American journal of cancer research},
  year={2016},
  volume={6 11},
  pages={
          2416-2430
        }
}
  • Erika Mora, E. Smith, +1 author D. Hertz
  • Published 2016
  • Medicine
  • American journal of cancer research
  • Vincristine is a chemotherapeutic agent that is a component of many combination regimens for a variety of malignancies, including several common pediatric tumors. Vincristine treatment is limited by a progressive sensorimotor peripheral neuropathy. Vincristine-induced peripheral neuropathy (VIPN) is particularly challenging to detect and monitor in pediatric patients, in whom the side effect can diminish long term quality of life. This review summarizes the current state of knowledge regarding… CONTINUE READING
    Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
    • 139
    • Highly Influenced
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 107 REFERENCES
    THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.
    • 503
    • Highly Influential
    • PDF
    Microtubule-binding agents: a dynamic field of cancer therapeutics
    • 1,055
    • PDF
    Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
    • 203